Company Filing History:
Years Active: 2004-2025
Title: Innovations of Timothy James Doran
Introduction
Timothy James Doran is an accomplished inventor based in Ocean Grove, Australia. He has made significant contributions to the field of biotechnology, particularly in the development of RNA molecules and methods for identifying antigen gene sequences. With a total of 2 patents, Doran's work has the potential to impact vaccine development and gene silencing techniques.
Latest Patents
Doran's latest patents include innovative advancements in RNA technology. The first patent focuses on new double-stranded RNA (dsRNA) structures and their application in gene silencing. This invention opens up new avenues for research and therapeutic applications in genetic engineering. The second patent pertains to methods of identifying gene sequences of potential vaccine antigens. This invention includes gene sequences and the polypeptides encoded by these sequences, which can be utilized to induce a protective immune response in animals. Notably, the invention emphasizes identifying potential antigen gene sequences of Mycoplasma and provides methods for identifying therapeutic antigenic gene sequences from nucleotide samples.
Career Highlights
Timothy James Doran is affiliated with the Commonwealth Scientific and Industrial Research Organisation (CSIRO), where he has been instrumental in advancing research in biotechnology. His work has garnered attention for its innovative approach to solving complex biological problems. Doran's expertise in RNA technology and antigen identification has positioned him as a key figure in his field.
Collaborations
Doran has collaborated with notable colleagues, including Robert John Moore and Neil Andrew Smith. These partnerships have fostered a collaborative environment that enhances the research output and innovation within the organization.
Conclusion
Timothy James Doran's contributions to biotechnology through his patents and collaborative efforts highlight his role as a leading inventor in the field. His work continues to pave the way for advancements in gene silencing and vaccine development.